- Binnopharm Group enters into agreement to acquire two anti-bacterial brands from Dr. Reddy’s in the Russia & CIS region
- Dr. Reddy's Laboratories enters into exclusive sales and distribution agreement with Novartis India Limited for select India brands
- Dr. Reddy's Laboratories announces the launch of its authorized generic version of VASOSTRICT® (vasopressin injection, USP) Vials in the U.S. Market
- Dr. Reddy’s Laboratories announces DCGI approval to the single-shot Sputnik Light vaccine in India
- Updates to the Press Release submitted on February 3, 2022
- Dr. Reddy's Laboratories enters into Definitive Agreement to acquire German medical cannabis firm Nimbus Health GmbH
- Dr. Reddy's included in S&P Global’s Sustainability Yearbook for the 2nd year and Bloomberg Gender-Equality Index for the 5th year in a row
- Akhil Ravi appointed CEO of Aurigene Pharmaceutical Services Ltd.